Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Oncotarget|March 27, 2025
Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMTLanlan Zhou, Leiqing Zhang, Jun Zhang, et al.
Cancer Research|August 22, 2015
Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53Shengliang Zhang, Lanlan Zhou, Bo Hong, et al.
Frontiers in Oncology|September 7, 2021
A Real-World Observation of Eltrombopag and Recombinant Human Thrombopoietin (rhTPO) in Lymphoma Patients With Chemotherapy Induced ThrombocytopeniaQiuhua Zhu, Shimei Yang, Wenbin Zeng, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic CancerTej Tummala, Ashley Sanchez Sevilla Uruchurtu, Arielle De La Cruz, et al.
Oncotarget|December 24, 2015
A multiplexed marker-based algorithm for diagnosis of carcinoma of unknown primary using circulating tumor cellsElizabeth M Matthew, Lanlan Zhou, Zhaohai Yang, et al.
Cancer Biology & Therapy|July 11, 2022
Clinical activity of 9-ING-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, in refractory adult T-Cell leukemia/lymphomaAndrew Hsu, Kelsey E Huntington, Andre De Souza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Frontiers in Immunology|April 18, 2022
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in LymphomaQiuhua Zhu, Huan Li, Shanshan Zheng, et al.
International Journal of Molecular Sciences|July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal CancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2017
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212Jessica Wagner, Christina Leah Kline, Marie D Ralff, et al.
Pageof 11